glp 1 example drugs GLP-1 Agonists: A Comprehensive Overview Designing GLP-1 delivery: structural perspectives

With any medicine, in rare cases, serious allergic reactions may occur

Despite being weak bases, the aminoglycosides are very large, hydrophilic molecules and have high pKa values, so they are highly ionized at physiologic pHs

Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes

This understanding has guided the development of amylin analogues like cagrilintide that retain therapeutic benefits while eliminating aggregation risks

Notably, cerebral IRI has been shown to rapidly induce secondary intestinal IRI, a finding that has opened up novel avenues for investigation in this field [130]